Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Arzneimittel-Forschung
|
January 1, 1976
Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat
D M Loew, H Depoortere, H R Buerki
Triangle; the Sandoz Journal of Medical Science
|
January 1, 1975
Neuropharmacological studies on hydergine
H Depoortere, D M Loew, J M Vigouret
Advances in Biochemical Psychopharmacology
|
January 1, 1980
Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine)
D M Loew, J M Vigouret, A Jaton
Naunyn-Schmiedebergs Archiv Fur Pharmakologie
|
January 1, 1970
[Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats]
D M Loew, H Depoortere, J M Vigouret
British Journal of Pharmacology
|
March 1, 1978
A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings]
A L Jaton, D M Loew, J M Vigouret
Postgraduate Medical Journal
|
January 1, 1976
Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine
D M Loew, A L Jaton, J M Vigouret
Psychopharmacologia
|
December 31, 1975
Inter-group aggression in mice: a new method for testing the effects of centrally active drugs
P P Zwirner, R D Porsolt, D M Loew
Gerontology
|
January 1, 1978
Changes in the rat electrocorticogram following administration of two dihydrogenated ergot derivatives
D I Carruthers-Jones, H Depoortere, D M Loew
British Journal of Pharmacology
|
March 1, 1976
Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist
A L Jaton, D M Loew, J M Vigouret
Experientia
|
May 15, 1978
Inhibition of reserpine-induced PGO waves in the cat by ergot derivatives
P E Züger, J M Vigouret, D M Loew
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Arzneimittel-Forschung
|
January 1, 1976
Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat
D M Loew, H Depoortere, H R Buerki
Triangle; the Sandoz Journal of Medical Science
|
January 1, 1975
Neuropharmacological studies on hydergine
H Depoortere, D M Loew, J M Vigouret
Advances in Biochemical Psychopharmacology
|
January 1, 1980
Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine)
D M Loew, J M Vigouret, A Jaton
Naunyn-Schmiedebergs Archiv Fur Pharmakologie
|
January 1, 1970
[Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats]
D M Loew, H Depoortere, J M Vigouret
British Journal of Pharmacology
|
March 1, 1978
A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings]
A L Jaton, D M Loew, J M Vigouret
Postgraduate Medical Journal
|
January 1, 1976
Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine
D M Loew, A L Jaton, J M Vigouret
Psychopharmacologia
|
December 31, 1975
Inter-group aggression in mice: a new method for testing the effects of centrally active drugs
P P Zwirner, R D Porsolt, D M Loew
Gerontology
|
January 1, 1978
Changes in the rat electrocorticogram following administration of two dihydrogenated ergot derivatives
D I Carruthers-Jones, H Depoortere, D M Loew
British Journal of Pharmacology
|
March 1, 1976
Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist
A L Jaton, D M Loew, J M Vigouret
Experientia
|
May 15, 1978
Inhibition of reserpine-induced PGO waves in the cat by ergot derivatives
P E Züger, J M Vigouret, D M Loew
Page
of 3